Moderna, Inc. (MRNA) Form 10-Q Quarterly Reports
Moderna, Inc. (MRNA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MRNA
CIK: 1682852
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerChristopher Pereira
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-14 | PRIMARY DOCUMENT | 0001682852-26-000187 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001959173-26-007387 | View SEC Doc Filr Page |
| 144 | 2026-10-14 | — | 144 Filing | 0001959173-26-007363 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | PRIMARY DOCUMENT | 0001682852-26-000185 | View SEC Doc Filr Page |
| 3 | 2026-10-05 | 2026-10-05 | PRIMARY DOCUMENT | 0001682852-26-000183 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-30 | 8-K | 0001193125-26-408289 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | PRIMARY DOCUMENT | 0001682852-26-000176 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001959173-26-006968 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | PRIMARY DOCUMENT | 0001682852-26-000174 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001959173-26-006932 | View SEC Doc Filr Page |
| 144 | 2026-09-10 | — | 144 Filing | 0001959173-26-006846 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | PRIMARY DOCUMENT | 0001682852-26-000172 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | PRIMARY DOCUMENT | 0001682852-26-000169 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | PRIMARY DOCUMENT | 0001682852-26-000167 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | PRIMARY DOCUMENT | 0001682852-26-000165 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | PRIMARY DOCUMENT | 0001682852-26-000163 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-27 | 8-K | 0001193125-26-378505 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001959173-26-006571 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | PRIMARY DOCUMENT | 0001682852-26-000161 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | PRIMARY DOCUMENT | 0001682852-26-000157 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | PRIMARY DOCUMENT | 0001682852-26-000155 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-12 | — | SCHEDULE 13G Filing | 0001422849-26-000128 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | PRIMARY DOCUMENT | 0001682852-26-000153 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002071 | View SEC Doc Filr Page |
| 144 | 2026-08-05 | — | 144 Filing | 0001959173-26-005661 | View SEC Doc Filr Page |